Kralj's group pioneered bacterial electrophysiology using genetically encoded voltage indicators, building high-throughput fluorescence-imaging platforms to map the proteins and dynamics governing membrane voltage in bacteria and to study bioelectric signaling and mechanosensation in cells. For context, this complements the established paradigm of NV-diamond ensemble magnetometry (Hahn-echo/DEER, nanoscale NMR, T1 relaxometry) operating near pT/√Hz sensitivity.

Designs programmable DNA nanodevices as quantitative fluorescent reporters to map second messengers in real time inside specific organelles of living cells. Research directions: (1) DNA origami ion-sensing nanodevices for pH, Cl-, Ca2+, HOCl, and membrane voltage with single-organelle addressability; (2) targeting nanodevices to endosomes, lysosomes, mitochondria, and ER to dissect organelle biology and disease mechanisms; (3) in vivo deployment in C. elegans and Drosophila. NIH Director's Pioneer Award 2022.

Kuimova pioneered the use of fluorescent 'molecular rotor' probes combined with fluorescence lifetime imaging (FLIM) to quantitatively map intracellular microviscosity in live cells and tissue, with applications spanning photodynamic therapy, membrane biophysics and G-quadruplex DNA imaging.

Kukura invented mass photometry, a label-free interferometric-scattering microscopy technique that mass-images single biomolecules in solution with precision rivalling native mass spectrometry; his group continues to expand the technique's hardware, analysis (including deep learning) and range of biomolecular applications, in close collaboration with Justin Benesch.

Kuncic works across medical physics and nanoscale systems: nanoparticle-enhanced radiotherapy and dosimetry (where high-Z nanoparticles act as local dose amplifiers and the physics question is energy deposition at nanometre scales), nanoparticle contrast agents and theranostics, and — separately — neuromorphic nanowire networks as physical computing substrates. The medical-physics thread is the relevant one here: it is about quantifying and imaging what a nanoscale probe does inside tissue. Positioned against the established body of NV-ensemble quantum sensing work — DEER, nanoscale NMR and T1 relaxometry protocols operating at pT/sqrt(Hz) field sensitivity — the nanoparticle-in-tissue problem she works on is the same delivery-and-quantification problem that determines whether an in-cell nanodiamond sensor operating near the pT/sqrt(Hz) regime reports anything biologically meaningful. Borderline inclusion; a candidate would be bringing quantum sensing to her, not the reverse.

Ladame develops biosensors and molecular diagnostic assays that detect cell-free circulating nucleic acid biomarkers (DNA/RNA) directly, without enzymatic amplification, for applications in early disease diagnosis and monitoring.

Lee leads TheLeeLab at Cambridge Chemistry, focused on developing cutting-edge biophysical single-molecule fluorescence methods to answer fundamental biological questions. Two major thrusts: (1) 3D super-resolution microscopy instrument development — the lab pioneered single-molecule light field microscopy (SMLFM) using a microlens array in the back focal plane, achieving ~10× speed improvement over double-helix PSF for volumetric imaging; also develops vortex light field microscopy (VLFM) for simultaneous 25 nm spatial / 3 nm spectral precision; (2) Biological applications — studying T-cell receptor signalling at the nanoscale (distribution of TCRs, microvilli-mediated close contacts), histone assembly during DNA replication and repair in fission yeast, and PSD-95 nanoclusters in mouse brain using 3D SMLM. A job posting (PDRA) was active in 2025 for T-cell imaging work with super-resolution and Fourier light-field microscopy.

Leifer develops closed-loop optical instrumentation that simultaneously records brain-wide calcium activity and delivers single-neuron optogenetic perturbations in freely moving C. elegans, building functional atlases of signal propagation and studying how whole-brain neural dynamics generate behavior. His group's whole-brain, cellular-resolution imaging in unrestrained animals is a benchmark advanced-microscopy approach for linking neural dynamics to behavior.

Lemke holds the chair of Synthetic Biophysics at JGU and is adjunct director at the Institute of Molecular Biology. The group's signature is combining genetic code expansion -- installing non-canonical amino acids so a dye can be clicked onto one chosen residue -- with single-molecule fluorescence: smFRET on intrinsically disordered proteins, super-resolution imaging of the nuclear pore complex and its FG-nucleoporin permeability barrier, and engineered membraneless organelles used as designer compartments in living cells. The result is single-molecule-resolution measurement of conformational dynamics and phase behaviour inside cells rather than in vitro. Relative to the established NV-ensemble quantum-sensing playbook (DEER, nanoscale NMR, T1 relaxometry at pT/sqrt(Hz) ensemble sensitivity), this is the strongest biosensing/advanced-microscopy host in Mainz: the labelling chemistry is precisely what a quantum-sensing postdoc would need to attach nanodiamonds or spin labels to a defined protein site, and the group already operates at the single-molecule sensitivity limit optically. Large, well-funded, internationally recruiting group.

Lichtman invented the multicolor 'Brainbow' fluorescent labeling method and pioneered large-scale, automated serial-section electron microscopy to reconstruct complete synaptic wiring diagrams (connectomes) of neural tissue, pushing spatial resolution and scale together to map circuit-level brain structure.